1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Controlled-Release Drug Delivery Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Controlled-Release Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Wurster Technique
1.4.3 Coacervation
1.4.4 Micro Encapsulation
1.4.5 Implants
1.4.6 Transdermal
1.4.7 Targeted Delivery
1.4.8 Others
1.5 Market by Application
1.5.1 Global Controlled-Release Drug Delivery Systems Market Share by Application: 2021-2026
1.5.2 Metered Dose Inhalers
1.5.3 Injectables
1.5.4 Transdermal and Ocular Patches
1.5.5 Infusion Pumps
1.5.6 Oral Controlled-Drug Delivery Systems
1.5.7 Drug Eluting Stents
1.5.8 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Controlled-Release Drug Delivery Systems Market
1.8.1 Global Controlled-Release Drug Delivery Systems Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Controlled-Release Drug Delivery Systems Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Controlled-Release Drug Delivery Systems Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Controlled-Release Drug Delivery Systems Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Controlled-Release Drug Delivery Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Controlled-Release Drug Delivery Systems Sales Volume Market Share by Region (2015-2020)
3.2 Global Controlled-Release Drug Delivery Systems Sales Revenue Market Share by Region (2015-2020)
3.3 North America Controlled-Release Drug Delivery Systems Sales Volume
3.3.1 North America Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.3.2 North America Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Controlled-Release Drug Delivery Systems Sales Volume
3.4.1 East Asia Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.5.1 Europe Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.6.1 South Asia Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.7.1 Southeast Asia Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.8.1 Middle East Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.9.1 Africa Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.10.1 Oceania Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.11.1 South America Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.11.2 South America Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Controlled-Release Drug Delivery Systems Sales Volume (2015-2020)
3.12.1 Rest of the World Controlled-Release Drug Delivery Systems Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Controlled-Release Drug Delivery Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Controlled-Release Drug Delivery Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Controlled-Release Drug Delivery Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Controlled-Release Drug Delivery Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Controlled-Release Drug Delivery Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Controlled-Release Drug Delivery Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Controlled-Release Drug Delivery Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Controlled-Release Drug Delivery Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Controlled-Release Drug Delivery Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Controlled-Release Drug Delivery Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Controlled-Release Drug Delivery Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Controlled-Release Drug Delivery Systems Sales Volume Market Share by Type (2015-2020)
14.2 Global Controlled-Release Drug Delivery Systems Sales Revenue Market Share by Type (2015-2020)
14.3 Global Controlled-Release Drug Delivery Systems Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Controlled-Release Drug Delivery Systems Consumption Volume by Application (2015-2020)
15.2 Global Controlled-Release Drug Delivery Systems Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Controlled-Release Drug Delivery Systems Business
16.1 Depomed, Inc.
16.1.1 Depomed, Inc. Company Profile
16.1.2 Depomed, Inc. Controlled-Release Drug Delivery Systems Product Specification
16.1.3 Depomed, Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Capsugel
16.2.1 Capsugel Company Profile
16.2.2 Capsugel Controlled-Release Drug Delivery Systems Product Specification
16.2.3 Capsugel Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Johnson and Johnson
16.3.1 Johnson and Johnson Company Profile
16.3.2 Johnson and Johnson Controlled-Release Drug Delivery Systems Product Specification
16.3.3 Johnson and Johnson Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Coating Place, Inc.
16.4.1 Coating Place, Inc. Company Profile
16.4.2 Coating Place, Inc. Controlled-Release Drug Delivery Systems Product Specification
16.4.3 Coating Place, Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Orbis Biosciences, Inc.
16.5.1 Orbis Biosciences, Inc. Company Profile
16.5.2 Orbis Biosciences, Inc. Controlled-Release Drug Delivery Systems Product Specification
16.5.3 Orbis Biosciences, Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Corium International, Inc.
16.6.1 Corium International, Inc. Company Profile
16.6.2 Corium International, Inc. Controlled-Release Drug Delivery Systems Product Specification
16.6.3 Corium International, Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Aradigm Corporation
16.7.1 Aradigm Corporation Company Profile
16.7.2 Aradigm Corporation Controlled-Release Drug Delivery Systems Product Specification
16.7.3 Aradigm Corporation Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Pfizer, Inc.
16.8.1 Pfizer, Inc. Company Profile
16.8.2 Pfizer, Inc. Controlled-Release Drug Delivery Systems Product Specification
16.8.3 Pfizer, Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Alkermes plc
16.9.1 Alkermes plc Company Profile
16.9.2 Alkermes plc Controlled-Release Drug Delivery Systems Product Specification
16.9.3 Alkermes plc Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Merck and Co., Inc.
16.10.1 Merck and Co., Inc. Company Profile
16.10.2 Merck and Co., Inc. Controlled-Release Drug Delivery Systems Product Specification
16.10.3 Merck and Co., Inc. Controlled-Release Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Controlled-Release Drug Delivery Systems Manufacturing Cost Analysis
17.1 Controlled-Release Drug Delivery Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Controlled-Release Drug Delivery Systems
17.4 Controlled-Release Drug Delivery Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Controlled-Release Drug Delivery Systems Distributors List
18.3 Controlled-Release Drug Delivery Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Controlled-Release Drug Delivery Systems (2021-2026)
20.2 Global Forecasted Revenue of Controlled-Release Drug Delivery Systems (2021-2026)
20.3 Global Forecasted Price of Controlled-Release Drug Delivery Systems (2015-2026)
20.4 Global Forecasted Production of Controlled-Release Drug Delivery Systems by Region (2021-2026)
20.4.1 North America Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.3 Europe Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.7 Africa Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.9 South America Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Controlled-Release Drug Delivery Systems Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Controlled-Release Drug Delivery Systems by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.2 East Asia Market Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.3 Europe Market Forecasted Consumption of Controlled-Release Drug Delivery Systems by Countriy
21.4 South Asia Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.5 Southeast Asia Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.6 Middle East Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.7 Africa Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.8 Oceania Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.9 South America Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
21.10 Rest of the world Forecasted Consumption of Controlled-Release Drug Delivery Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer